Oramed Pharmaceuticals Accounts Payable

Oramed Pharmaceuticals (ORMP) currently reports a accounts payable of $480K as of March 2026. That compares with $510K in the prior-year period — down 5.5% year over year. Use the charts on this page to explore Oramed Pharmaceuticals's accounts payable history and peer comparisons.

Oramed Pharmaceuticals's accounts payable decreased from $510K to $480K — a 5.5% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Oramed Pharmaceuticals reported $480K in accounts payable as of March 2026. That compares with $510K in the prior-year period — down 5.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $480K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Oramed Pharmaceuticals, and consider following ORMP for alerts when major investors trade the stock.

Oramed Pharmaceuticals is classified in the Healthcare sector. On accounts payable, it currently shows $480K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ORMP with unrelated industries.